Thalassemia is an inherited blood disorder characterized by reduced or absent hemoglobin. It is fairly common worldwide, with thousands of new cases in infants born each year, particularly in Mediterranean, Middle Eastern, South Asian and Southeast Asian countries. Treatment involves regular blood transfusions, iron chelation therapy, and potentially a bone marrow transplant. Living with thalassemia can be difficult, as patients rely on blood donations and have complex medical needs. This document outlines strategies to help thalassemia patients in Sulaimani, including establishing regular blood donor programs at universities, increasing public education about the disease, and motivating blood donation.